Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Biocryst Pharmaceuticals Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 242
- +16 vs. Q4 2022
- Shares held
- 170.3M
- +13.4M (+8.5%) vs. Q4 2022
- Total value
- $1.42B
- −$377.1M (−20.9%) vs. Q4 2022
- New holders
- 40
- 94 more added
- Sold out
- 24
- 69 more reduced
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 796,299 | $6.64M | 0.00% | −809,395−50.4% | Reduced |
| Rafferty Asset Management, LLC | 820,521 | $6.84M | 0.05% | +52,448+6.8% | Added |
| First Manhattan Co | 874,840 | $7.30M | 0.03% | −993,832−53.2% | Reduced |
| Norges Bank | 884,863 | $7.38M | 0.00% | −267,253−23.2% | Reduced |
| Citadel Advisors LLC | 905,070 | $7.55M | 0.01% | +846,651+1,449.3% | Added |
| Kynam Capital Management, LP | 1,000,000 | $8.34M | 1.08% | +1,000,000 | New |
| Prosight Management, LP | 1,074,593 | $8.96M | 4.29% | +957,861+820.6% | Added |
| Eventide Asset Management, LLC | 1,102,889 | $9.20M | 0.17% | +1,102,889 | New |
| Goldman Sachs Group Inc | 1,126,706 | $9.40M | 0.00% | −4,988−0.4% | Reduced |
| Saturn V Capital Management LLC | 1,163,535 | $9.70M | 7.25% | +823,372+242.1% | Added |
| ExodusPoint Capital Management, LP | 1,221,681 | $10.2M | 0.12% | +1,199,839+5,493.3% | Added |
| Alkeon Capital Management LLC | 1,268,852 | $10.6M | 0.07% | −216,965−14.6% | Reduced |
| Two Sigma Investments, LP | 1,340,318 | $11.2M | 0.03% | +826,411+160.8% | Added |
| Charles Schwab Investment Management Inc | 1,423,120 | $11.9M | 0.00% | +2,733+0.2% | Added |
| Tang Capital Management LLC | 1,600,000 | $13.3M | 1.99% | +150,000+10.3% | Added |
| Morgan Stanley | 1,610,670 | $13.4M | 0.00% | +454,939+39.4% | Added |
| Northern Trust Corp | 1,763,099 | $14.7M | 0.00% | +15,639+0.9% | Added |
| Segall Bryant & Hamill, LLC | 1,837,854 | $15.3M | 0.17% | +168,855+10.1% | Added |
| Stifel Financial Corp | 1,844,074 | $15.4M | 0.02% | 00.0% | Unchanged |
| Braidwell LP | 1,945,134 | $16.2M | 0.54% | +1,945,134 | New |
| Jacobs Levy Equity Management, Inc | 2,034,343 | $17.0M | 0.10% | +566,237+38.6% | Added |
| PFM Health Sciences, LP | 2,162,411 | $18.0M | 0.83% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 2,202,712 | $18.4M | 0.05% | +231,800+11.8% | Added |
| Rock Springs Capital Management LP | 2,334,085 | $19.5M | 0.46% | +443,348+23.4% | Added |
| GW&K Investment Management, LLC | 2,603,931 | $21.7M | 0.21% | +876,844+50.8% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,765,000 | $23.1M | 0.51% | +2,765,000 | New |
| Artisan Partners Limited Partnership | 2,837,924 | $23.7M | 0.04% | −40,503−1.4% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,887,739 | $24.1M | 0.08% | +25,352+0.9% | Added |
| FMR LLC | 3,167,510 | $26.4M | 0.00% | −3,953,485−55.5% | Reduced |
| Bank of America Corp | 3,614,333 | $30.1M | 0.00% | +2,627,536+266.3% | Added |
| Geode Capital Management, LLC | 3,653,556 | $30.5M | 0.00% | +187,006+5.4% | Added |
| RP Management, LLC | 3,846,154 | $32.1M | 44.43% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 4,293,396 | $35.8M | 0.02% | −137,718−3.1% | Reduced |
| Millennium Management LLC | 4,437,329 | $37.0M | 0.04% | +4,421,538+28,000.4% | Added |
| Eversept Partners, LP | 4,520,724 | $37.7M | 3.39% | +3,640,237+413.4% | Added |
| Assenagon Asset Management S.A. | 4,967,837 | $41.4M | 0.16% | +2,377,445+91.8% | Added |
| Pictet Asset Management SA | 5,618,372 | $46.9M | 0.06% | +333,024+6.3% | Added |
| Avoro Capital Advisors LLC | 10,420,000 | $86.9M | 1.29% | +1,370,000+15.1% | Added |
| State Street Corp | 11,389,623 | $95.0M | 0.01% | +262,762+2.4% | Added |
| Baker Bros. Advisors LP | 12,710,818 | $106.0M | 0.58% | 00.0% | Unchanged |
| BlackRock Inc. | 14,824,798 | $123.6M | 0.00% | −94,157−0.6% | Reduced |
| Vanguard Group Inc | 14,826,113 | $123.6M | 0.00% | +621,718+4.4% | Added |
| Fairmount Funds Management LLC | 0 | $0 | 0.00% | −2,543,107−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −1,328,291−100.0% | Sold out |
| E. Ohman J:or Asset Management AB | 0 | $0 | 0.00% | −145,921−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −134,989−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −106,629−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −78,216−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −62,105−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −25,637−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −23,910−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −21,100−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −14,734−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −14,414−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,791−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,520−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −10,584−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,800−100.0% | Sold out |
| Virtus Fund Advisers, LLC | 0 | $0 | 0.00% | −1,900−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −1,170−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −178−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Neo Ivy Capital Management | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Semmax Financial Advisors Inc. | – | – | – | – | Not filed |
| Heritage Wealth Management, LLC | – | – | – | – | Not filed |